DTX1 and central nervous system cancer: Huber et al. discovered that GBMs have higher levels of Deltex1 (DTX1) expression than normal brain cells and that many pathways, including RTK/PI3K/PKB and the antiapoptotic protein Mcl-1, are implicated in glioma aggressiveness [117].